...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics

It's pretty simple now Narmac...

We need to prove the science because we failed not once but twice.  Moreover, we are trying to prove an entirely new science and way of doing and so at this point in our journey we must prove the science.   

in other words we can market all we want but it isn't going to have any kind of positive impact like we all want.  So I'm staying long and strong and will remain patient throughout up and until a conclusion.  

10BagR

Share
New Message
Please login to post a reply